Remove Disease Remove Immune Response Remove Nurses
article thumbnail

Research Roundup: Healthcare Workers Highest Risk for COVID-19 and More

The Pharma Data

A study out of Rutgers University found that healthcare staffers, especially nurses, have a higher prevalence of COVID-19 than non-healthcare workers. Centers for Disease Control and Prevention (CDC), there were more than 216,000 confirmed COVID-19 cases in healthcare workers in the U.S., As of November 15, 2020, according to the U.S.

article thumbnail

The Long Road to End Tuberculosis

Codon

Physicians working in the early 20th century had little choice but to treat the world’s most rampant infectious disease with methods such as these. But even now, more than a century later, TB remains the deadliest infectious disease on Earth, killing about 1.2 million people every year. tuberculosis.

Vaccine 92
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Even in Moderate Cases, COVID-19 Is Causing Long-Term Neurological Harm

The Pharma Data

Some problems, she said, are related to an overactive immune response — such as Guillain-Barre syndrome, where the immune system attacks the body’s nerves. And while most left the hospital, the majority were released to skilled nursing facilities or other care to continue their recovery.

article thumbnail

People Should Know That COVID Vaccine Might Spur Transient Sickness: CDC Experts

The Pharma Data

Centers for Disease Control and Prevention stressed that Americans who get a shot shouldn’t be surprised if they feel under the weather for a few days afterwards. “These are immune responses, so if you feel something after vaccination, you should expect to feel that. Earlier Thursday, the U.S.

Vaccine 52
article thumbnail

KetosisNOW – Bulletproof Keto “Hack” To Melt Excess Fat

The Pharma Data

You will also see an improvement in your immune. are not intended to diagnose, treat, cure or prevent any disease. If you are pregnant, nursing, taking medication, or have a medical condition, consult your physician before using our. We are confident. weight reduction and fat loss within 30 days. products. * © Copyright 2020.

article thumbnail

CheckMate -577, a Phase 3 Trial Evaluating Opdivo (nivolumab) as Adjuvant Therapy for Patients with Resected Esophageal or Gastroesophageal Junction Cancer, Meets Primary Endpoint of Disease-Free Survival

The Pharma Data

.–( BUSINESS WIRE )– Bristol Myers Squibb (NYSE: BMY) today announced the Phase 3 CheckMate -577 trial evaluating Opdivo (nivolumab) as an adjuvant therapy for patients with resected esophageal or gastroesophageal junction (GEJ) cancer met its primary endpoint of disease-free survival (DFS) at a pre-specified interim analysis.

article thumbnail

Regeneron Announces Encouraging Initial Data from COVID-19 Antibody Cocktail Trial in Hospitalized Patients on Low-flow Oxygen

The Pharma Data

The analysis was prospectively designed to focus on patients who had not yet mounted their own immune response to SARS-CoV-2 (i.e., 35 — Have chronic kidney disease — Have diabetes — Have immunosuppressive disease — Are currently receiving immunosuppressive treatment — Are ?65